Infectious Diseases News and Research

RSS

Johns Hopkins experts provide useful information to help prevent transmission of Zika virus

With Zika virus emerging as a public health concern worldwide, experts at The Johns Hopkins Hospital are closely monitoring the spread of the mosquito-borne illness and offering useful information to help prevent transmission.

16 Feb 2016

CMV-based vaccine provides protection against Ebola virus

As the latest in a series of studies, researchers at Plymouth University, National Institutes of Health and University of California, Riverside, have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model.

16 Feb 2016

Experimental vaccine shows effectiveness in Ebola vaccine trial

An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa -- and the approach could establish a new way of responding to outbreaks of emerging pathogens, including the Zika virus.

16 Feb 2016

Variations in Tie2 gene play significant role in patient responses to infections

Major infections such as influenza and bacterial sepsis kill millions of people each year, often resulting fro dangerous complications that impair the body's blood vessels. But the reasons why some patients experience these dramatic responses to infections -- and others don't -- have been unclear.

16 Feb 2016

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

In response to the global call for urgently needed resources to fight the spread of the Zika virus, RB is announcing a Zika Relief Package of $1 million USD consisting of both cash and product donations that will be made available to health authorities and international NGOs battling the outbreak.

16 Feb 2016

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years.

15 Feb 2016

Tick genome study sheds light on occurrences of Lyme disease

After a decade-long research effort the genome of the deer tick has been sequenced by an international team of scientists, including researchers from the SIB Swiss Institute of Bioinformatics.

12 Feb 2016

UW-Madison research team starts work on Zika virus infection

In October, when David O'Connor last visited Brazil as part of a decade-long research program studying drug-resistant strains of HIV, one of his Brazilian collaborators had a request.

11 Feb 2016

Zika virus can have substantial economic impact in Americas

"Zika virus isn't going anywhere," says Frank Esper, MD, infectious disease specialist at University Hospitals Rainbow Babies & Children's Hospital. "If it's anything near what happened with SARS or with Ebola, people are going to be very hesitant to travel to those areas.

11 Feb 2016

First case of Zika virus found in Ohio

"This is not unexpected," says Frank Esper, MD, infectious disease specialist at University Hospitals Rainbow Babies & Children's Hospital in Cleveland, after learning of the first case of Zika virus in Ohio, found in a Cleveland woman who traveled to Haiti. "We know people are going to come back and they're going to have the Zika virus."

11 Feb 2016

ESCMID gathers more solid data to better assess Zika virus risks, prepares for possible outbreak in Africa, Europe

Experts at the European Society of Clinical Microbiology and Infectious Diseases – an organization promoting research, risk assessment, knowledge sharing and best practices in the fight against infectious diseases – are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.

10 Feb 2016

Oral therapeutic drug shows promise against recurrent C. difficile infection

Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.

10 Feb 2016

ZAO provides platform for scientists, clinicians to share new research and clinical data on Zika

ZAO provides a platform for scientists and clinicians to publish their findings and source data on Zika and its mosquito vectors within days of submission, so that research, medical and government personnel can keep abreast of the rapidly evolving outbreak.

10 Feb 2016

Mayo Clinic researchers discover new bacterial species that triggers Lyme disease in people

Mayo Clinic researchers, in collaboration with the Centers for Disease Control and Prevention and health officials from Minnesota, North Dakota and Wisconsin, have discovered a new bacterial species that causes Lyme disease in people. The new species has been provisionally named Borrelia mayonii. Prior to this finding, the only species believed to cause Lyme disease in North America was Borrelia burgdorferi.

9 Feb 2016

Researchers show how antiretroviral therapy reduces HIV infection in female reproductive tract

For the first time, investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have determined how antiretroviral therapy (ART) affects the way HIV disseminates and establishes infection in the female reproductive tract.

9 Feb 2016

UM SOM researchers reveal genetic makeup of various strains of E. coli

A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.

9 Feb 2016

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration has cleared the Company's Investigational New Drug (IND) application for SB-318, a single treatment strategy intended to provide a life-long therapy for Mucopolysaccharidosis Type I (MPS I).

8 Feb 2016

Discovery takes researchers one step closer to preventing C. diff

Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant C. difficile, one of the fastest growing bacteria superbugs, according to a new study published by Stuart Johnson, MD, of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and the Hines VA Medical Hospital.

5 Feb 2016

Early use of influenza drug in pregnant women with flu may reduce length of stay in hospital

Pregnant women are at higher risk for serious illness and complications, including death, from influenza. For expectant mothers hospitalized with flu, early treatment with the influenza antiviral drug oseltamivir may shorten their time in the hospital, especially in severe cases, suggests a new study published in The Journal of Infectious Diseases and available online.

5 Feb 2016

Study: Prior surgical abortion appears to increase risk of later preterm birth

Surgical methods used in a common form of abortion or to clear the womb after a spontaneous miscarriage appears to significantly increase the risk of a later preterm birth, say researchers at Thomas Jefferson University who analyzed 36 studies that enrolled more than 1 million women.

4 Feb 2016

Infectious Diseases News and Research

Johns Hopkins experts provide useful information to help prevent transmission of Zika virus

CMV-based vaccine provides protection against Ebola virus

Experimental vaccine shows effectiveness in Ebola vaccine trial

Variations in Tie2 gene play significant role in patient responses to infections

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

Tick genome study sheds light on occurrences of Lyme disease

UW-Madison research team starts work on Zika virus infection

Zika virus can have substantial economic impact in Americas

First case of Zika virus found in Ohio

ESCMID gathers more solid data to better assess Zika virus risks, prepares for possible outbreak in Africa, Europe

Oral therapeutic drug shows promise against recurrent C. difficile infection

ZAO provides platform for scientists, clinicians to share new research and clinical data on Zika

Mayo Clinic researchers discover new bacterial species that triggers Lyme disease in people

Researchers show how antiretroviral therapy reduces HIV infection in female reproductive tract

UM SOM researchers reveal genetic makeup of various strains of E. coli

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Discovery takes researchers one step closer to preventing C. diff

Early use of influenza drug in pregnant women with flu may reduce length of stay in hospital

Study: Prior surgical abortion appears to increase risk of later preterm birth

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News